Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication August 14, 2017
- Accepted for publication November 3, 2017
- Published online June 1, 2018.
Article Versions
- previous version (November 30, 2017 - 12:47).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Sudeepti Southekal,
- Michael D. Devous Sr.,
- Ian Kennedy,
- Michael Navitsky,
- Ming Lu,
- Abhinay D. Joshi,
- Michael J. Pontecorvo and
- Mark A. Mintun
- Avid Radiopharmaceuticals, Inc. (a wholly owned subsidiary of Eli Lilly and Company), Philadelphia Pennsylvania
- For correspondence or reprints contact: Sudeepti Southekal, Avid Radiopharmaceuticals, 3711 Market St., Philadelphia, PA 19104. E-mail: southekal{at}avidrp.com
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Improved Correlation of 18F-Flortaucipir PET SUVRs and Clinical Stages in the Alzheimer Disease Continuum with the MUBADA/PERSI-Based Analysis
- Genistein effect on cognition in early Alzheimers disease patients. The GENIAL clinical trial
- Tau PET Imaging in Neurodegenerative Disorders
- An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with 18F-PM-PBB3 (18F-APN-1607)
- Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimers disease
- Microglial activation and tau burden predict cognitive decline in Alzheimers Disease
- Connectome-mediated prediction of future tau-PET burden in Alzheimers disease
- Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study
- Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span